IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 223 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $229,000 | -56.6% | 11,975 | -44.1% | 0.14% | -58.6% |
| Q3 2021 | $528,000 | -4.2% | 21,430 | +1.3% | 0.33% | -2.4% |
| Q2 2021 | $551,000 | +66.5% | 21,159 | +102.5% | 0.33% | +42.1% |
| Q1 2021 | $331,000 | +28.3% | 10,450 | +88.3% | 0.24% | -3.7% |
| Q4 2020 | $258,000 | +15.7% | 5,550 | -18.1% | 0.24% | +5.2% |
| Q3 2020 | $223,000 | -8.6% | 6,775 | -23.7% | 0.23% | -6.5% |
| Q2 2020 | $244,000 | +14.6% | 8,875 | +25.0% | 0.25% | -2.7% |
| Q1 2020 | $213,000 | – | 7,100 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,944,201 | $27,999,000 | 13.31% |
| Broadfin Capital, LLC | 4,328,303 | $41,162,000 | 8.50% |
| GREAT POINT PARTNERS LLC | 5,567,348 | $52,945,000 | 5.24% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $20,811,000 | 5.01% |
| Avoro Capital Advisors LLC | 10,530,862 | $100,148,000 | 4.33% |
| Prosight Management, LP | 917,080 | $8,721,000 | 3.82% |
| Perceptive Advisors | 12,235,811 | $116,362,000 | 3.28% |
| Ghost Tree Capital, LLC | 1,150,000 | $10,937,000 | 2.86% |
| QVT Financial LP | 1,021,361 | $9,241,000 | 2.32% |
| Cheyne Capital Management (UK) LLP | 186,500 | $1,774,000 | 1.66% |